Detalhe da pesquisa
1.
Insights into the Mechanism of Action of Highly Diluted Biologics.
J Immunol
; 205(5): 1345-1354, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727888
2.
Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
J Med Virol
; 89(5): 759-766, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27769099
3.
The phenomenon of released-activity. Reply on comment on Don et al.: Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
J Med Virol
; 89(7): 1127-1130, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28036118
4.
Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
Antivir Ther
; 22(4): 345-351, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27924780
5.
Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results.
Antiviral Res
; 142: 185-192, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356234
6.
Retraction: Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
Antivir Ther
; 24(3): 235, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31348765
7.
Retraction notice to "Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results" [Antiviral Research 142 (2017) 185-192].
Antiviral Res
; 164: 176, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885298